These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11059026)

  • 1. [Early detection of exacerbation of lung infections in patients with cystic fibrosis by means of daily spirometry].
    Izbicki G; Trachsel D; Rutishauser M; Perruchoud AP; Tamm M
    Schweiz Med Wochenschr; 2000 Sep; 130(39):1361-5. PubMed ID: 11059026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: the early intervention in cystic fibrosis exacerbation (eICE) trial.
    Lechtzin N; West N; Allgood S; Wilhelm E; Khan U; Mayer-Hamblett N; Aitken ML; Ramsey BW; Boyle MP; Mogayzel PJ; Goss CH
    Contemp Clin Trials; 2013 Nov; 36(2):460-9. PubMed ID: 24055998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in spirometry during consecutive admissions for infective pulmonary exacerbations in adolescent and adult cystic fibrosis.
    Packe GE; Hodson ME
    Respir Med; 1992 Jan; 86(1):45-8. PubMed ID: 1565817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-time, once-daily monitoring of symptoms and FEV in cystic fibrosis patients--a feasibility study using a novel device.
    Sarfaraz S; Sund Z; Jarad N
    Clin Respir J; 2010 Apr; 4(2):74-82. PubMed ID: 20565480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary exacerbations in cystic fibrosis.
    Stenbit AE; Flume PA
    Curr Opin Pulm Med; 2011 Nov; 17(6):442-7. PubMed ID: 21881509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.
    Fuchs HJ; Borowitz DS; Christiansen DH; Morris EM; Nash ML; Ramsey BW; Rosenstein BJ; Smith AL; Wohl ME
    N Engl J Med; 1994 Sep; 331(10):637-42. PubMed ID: 7503821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resting energy expenditure in young patients with cystic fibrosis receiving antibiotic therapy for acute respiratory exacerbations.
    Castro M; Diamanti A; Gambarara M; Bella S; Lucidi V; Papadatou B; Ferretti F; Rosati P; Rupi E
    Clin Nutr; 2002 Apr; 21(2):141-4. PubMed ID: 12056786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in lung function measured by spirometry and the forced oscillation technique in cystic fibrosis patients undergoing treatment for respiratory tract exacerbation.
    Ren CL; Brucker JL; Rovitelli AK; Bordeaux KA
    Pediatr Pulmonol; 2006 Apr; 41(4):345-9. PubMed ID: 16496336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibiotic therapy and effects of respiratory physiotherapy techniques in cystic fibrosis patients treated for acute lung exacerbations: an experimental study].
    da Silva Santos CI; Gonçalves de Oliveira Ribeiro MA; Moreno Morcillo A; Fernando Ribeiro A; Dirceu Ribeiro J
    Arch Bronconeumol; 2010 Jun; 46(6):310-6. PubMed ID: 20417019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolongation of antibiotic treatment for cystic fibrosis pulmonary exacerbations.
    Waters V; Stanojevic S; Klingel M; Chiang J; Sonneveld N; Kukkar R; Tullis E; Ratjen F
    J Cyst Fibros; 2015 Nov; 14(6):770-6. PubMed ID: 26265220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty acid supplements improve respiratory, inflammatory and nutritional parameters in adults with cystic fibrosis.
    Olveira G; Olveira C; Acosta E; Espíldora F; Garrido-Sánchez L; García-Escobar E; Rojo-Martínez G; Gonzalo M; Soriguer F
    Arch Bronconeumol; 2010 Feb; 46(2):70-7. PubMed ID: 20045240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteopathic manipulative treatment for inpatients with pulmonary exacerbations of cystic fibrosis: effects on spirometry findings and patient assessments of breathing, anxiety, and pain.
    Swender DA; Thompson G; Schneider K; McCoy K; Patel A
    J Am Osteopath Assoc; 2014 Jun; 114(6):450-8. PubMed ID: 24917632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of pulmonary hyperinflation and trapped gas associated with genetic and environmental factors in children with cystic fibrosis.
    Kraemer R; Baldwin DN; Ammann RA; Frey U; Gallati S
    Respir Res; 2006 Nov; 7(1):138. PubMed ID: 17137500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of pulmonary exacerbations in patients with cystic fibrosis infected with multi-resistant bacteria.
    Block JK; Vandemheen KL; Tullis E; Fergusson D; Doucette S; Haase D; Berthiaume Y; Brown N; Wilcox P; Bye P; Bell S; Noseworthy M; Pedder L; Freitag A; Paterson N; Aaron SD
    Thorax; 2006 Nov; 61(11):969-74. PubMed ID: 16844728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved lung function and body mass index associated with long-term use of Macrolide antibiotics.
    Pirzada OM; McGaw J; Taylor CJ; Everard ML
    J Cyst Fibros; 2003 Jun; 2(2):69-71. PubMed ID: 15463852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis.
    de Boer K; Vandemheen KL; Tullis E; Doucette S; Fergusson D; Freitag A; Paterson N; Jackson M; Lougheed MD; Kumar V; Aaron SD
    Thorax; 2011 Aug; 66(8):680-5. PubMed ID: 21680566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extending the course of intravenous antibiotics in adult patients with cystic fibrosis with acute pulmonary exacerbations.
    Sequeiros IM; Jarad NA
    Chron Respir Dis; 2012; 9(4):213-20. PubMed ID: 22637747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for increased need for intravenous antibiotics for pulmonary exacerbations in adult patients with cystic fibrosis.
    Jarad NA; Giles K
    Chron Respir Dis; 2008; 5(1):29-33. PubMed ID: 18303099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on treatment of pulmonary exacerbations in cystic fibrosis.
    Smyth A
    Curr Opin Pulm Med; 2006 Nov; 12(6):440-4. PubMed ID: 17053495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with response to treatment of pulmonary exacerbations in cystic fibrosis patients.
    Waters VJ; Stanojevic S; Sonneveld N; Klingel M; Grasemann H; Yau YC; Tullis E; Wilcox P; Freitag A; Chilvers M; Ratjen FA
    J Cyst Fibros; 2015 Nov; 14(6):755-62. PubMed ID: 25690407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.